ATE454467T1 - Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen - Google Patents
Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellenInfo
- Publication number
- ATE454467T1 ATE454467T1 AT02710865T AT02710865T ATE454467T1 AT E454467 T1 ATE454467 T1 AT E454467T1 AT 02710865 T AT02710865 T AT 02710865T AT 02710865 T AT02710865 T AT 02710865T AT E454467 T1 ATE454467 T1 AT E454467T1
- Authority
- AT
- Austria
- Prior art keywords
- transcription
- cells
- expression products
- cancerical
- treating
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200100151A ES2185472B1 (es) | 2001-01-23 | 2001-01-23 | Empleo del gen slug, o de sus productos de transcripcion o expresion, en la deteccion y/o tratamiento de celulas cancerosas. |
PCT/ES2002/000026 WO2002059361A1 (es) | 2001-01-23 | 2002-01-23 | Empleo del gen slug o de sus productos de transcripcion o expresion en la deteccion y/o tratamiento de celulas cancerosas |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE454467T1 true ATE454467T1 (de) | 2010-01-15 |
Family
ID=8496481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02710865T ATE454467T1 (de) | 2001-01-23 | 2002-01-23 | Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen |
Country Status (7)
Country | Link |
---|---|
US (1) | US7776519B2 (de) |
EP (1) | EP1354962B1 (de) |
JP (1) | JP2004520045A (de) |
AT (1) | ATE454467T1 (de) |
DE (1) | DE60234991D1 (de) |
ES (4) | ES2185472B1 (de) |
WO (1) | WO2002059361A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2195751B1 (es) * | 2001-11-27 | 2005-04-01 | Universidad De Salamanca (Otri) | Mamiferos no humanos transgenicos como modelos para patologias humanas con origen en celulas stem. |
ES2253028B1 (es) * | 2003-05-30 | 2007-08-01 | Universidad De Salamanca | "empleo del gen slug, sus productos de transcripcion o expresion, y/o compuestos inhibidores o estimuladores de la expresion de slug para conferir radioresistencia o radioproteccion celular. |
ES2301268B1 (es) * | 2004-10-25 | 2009-05-01 | Centro De Investigacion Biomolecular Aplicada Salamanca, S.L. | Empleo del gen slug, o de sus productos de replicacion, transcripcion o expresion, en la identificacion, diagnostico, prevencion o tratamiento de la diseminacion del cancer y/o desarrollo de metastasis. |
CA2656548A1 (en) * | 2005-06-30 | 2007-01-11 | Whitehead Institute | Progenitor cells and uses thereof |
WO2010003103A2 (en) * | 2008-07-02 | 2010-01-07 | Whitehead Institute For Biomedical Research | Non-human mammals with t or b cells having predefined specificity |
KR101805181B1 (ko) | 2016-09-02 | 2017-12-07 | 충북대학교 산학협력단 | 인산화된 slug 단백질의 유사분열 세포에 대한 신규한 바이오 마커로서의 용도 |
WO2023126958A1 (en) * | 2021-12-30 | 2023-07-06 | Mestastop Solutions Private Limited | Method for producing a spontaneous metastasis model |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
JP2007516693A (ja) * | 2003-06-09 | 2007-06-28 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | 癌の治療および診断のための組成物および方法 |
-
2001
- 2001-01-23 ES ES200100151A patent/ES2185472B1/es not_active Expired - Fee Related
-
2002
- 2002-01-23 EP EP20020710865 patent/EP1354962B1/de not_active Expired - Lifetime
- 2002-01-23 WO PCT/ES2002/000026 patent/WO2002059361A1/es active Application Filing
- 2002-01-23 US US10/466,817 patent/US7776519B2/en not_active Expired - Fee Related
- 2002-01-23 JP JP2002559843A patent/JP2004520045A/ja active Pending
- 2002-01-23 DE DE60234991T patent/DE60234991D1/de not_active Expired - Lifetime
- 2002-01-23 AT AT02710865T patent/ATE454467T1/de not_active IP Right Cessation
- 2002-01-23 ES ES02710865T patent/ES2339335T3/es not_active Expired - Lifetime
- 2002-11-15 ES ES200202633A patent/ES2241402B1/es not_active Expired - Fee Related
- 2002-11-15 ES ES200202634A patent/ES2242469B1/es not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2185472A1 (es) | 2003-04-16 |
US20060141454A1 (en) | 2006-06-29 |
WO2002059361A1 (es) | 2002-08-01 |
ES2241402B1 (es) | 2007-02-16 |
JP2004520045A (ja) | 2004-07-08 |
EP1354962A1 (de) | 2003-10-22 |
ES2241402A1 (es) | 2005-10-16 |
ES2242469B1 (es) | 2006-07-16 |
ES2185472B1 (es) | 2004-10-16 |
EP1354962B1 (de) | 2010-01-06 |
DE60234991D1 (de) | 2010-02-25 |
ES2242469A1 (es) | 2005-11-01 |
ES2339335T3 (es) | 2010-05-19 |
US7776519B2 (en) | 2010-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ593289A (en) | Anti-neuropilin-1 antibodies for treating angiogenesis | |
DE69503129D1 (de) | Pteridin-nukleotidderivate als fluoreszierende sonden | |
ATE454468T1 (de) | Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose | |
ATE226643T1 (de) | Genetische diagnose und pharmazeutische produkte zur behandlung von prostatakrebs | |
PT2380985E (pt) | Células que expressam a vitamina k epóxido reductase e sua utilização | |
AU2004205878A8 (en) | Gene expression markers for breast cancer prognosis | |
ATE531529T1 (de) | Wertdokument, herstellung und prüfung von wertdokumenten | |
AU2003293141A8 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
DE602004015626D1 (de) | Bei brustkrebs | |
ATE454467T1 (de) | Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen | |
DE60027045D1 (de) | Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe | |
AU2003264078A8 (en) | Method for analyzing body fluids for the presence of cancer cells, use thereof, corresponding analysis kits, and use of specific active substances for treating cancer | |
MXPA05014220A (es) | Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos. | |
ATE229571T1 (de) | Nachweis und identifizierung von nicht-polio enteroviren | |
WO2003025141A3 (en) | Genetic analysis for stratification of cancer risk | |
WO2003030725A3 (en) | Pancreatic cancer diagnosis and therapies | |
ATE333521T1 (de) | Detektion von vancomycin-resistenten enterococcus-subspezies | |
WO2003062826A3 (en) | Materials and methods for examining and treating nasopharyngeal carcinoma | |
HK1085538A1 (en) | Assessing neuronal damage from blood samples | |
EP1304377A4 (de) | Verfahren zum Nachweis von Krebs | |
WO2002044419A3 (en) | Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2002044417A3 (en) | Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
Widschwendter | 5-Methylcytosine—the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer? | |
DE60325579D1 (de) | Krebsbehandlung | |
AR060955A1 (es) | Utilizacion del gen adamts4 y de los polimorfismos de proteina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |